Table: Kaken Pharmaceutical -2023/24 group results

KAKEN PHARMACEUTICAL

14/05/2024 05:30

May 14 (Reuters)- 
          Kaken Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           72.04           72.98          75.10                 
               (-1.3 pct)      (-4.0 pct)     (+4.2 pct)               
  Operating        9.51            8.00           7.40                 
               (+18.9 pct)     (-53.1 pct)    (-22.2 pct)              
  Recurring        9.95            8.73           7.80                 
               (+14.0 pct)     (-50.3 pct)    (-21.6 pct)              
  Net
  Net              8.03            5.44           5.60                 
               (+47.5 pct)     (-43.0 pct)    (-30.2 pct)              
  EPS          212.67 yen      144.80 yen     147.88 yen               
  Ann Div      150.00 yen      150.00 yen     150.00 yen               
  -Q2 Div       75.00 yen       75.00 yen      75.00 yen               
  -Q4 Div       75.00 yen       75.00 yen      75.00 yen               
  
  NOTE - Kaken Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T